Jim Simons Quoin Pharmaceuticals, Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$4.36 - $17.12 $63,359 - $248,787
14,532 Added 28.83%
64,932 $29,000
Q1 2022

May 13, 2022
SELL
$13.25 - $26.75 $437,064 - $882,375
-32,986 Reduced 39.56%
50,400 $67,000
Q4 2021

Feb 11, 2022
BUY
$22.38 - $232.38 $1.87 Million - $19.4 Million
83,386 New
83,386 $152,000

About Quoin Pharmaceuticals, Ltd.

QNRX Quotes by TradingView
  • Ticker QNRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,846,600
  • Market Cap $3.15M
  • Description
  • Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targe...
More about QNRX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email